Skip to main content
OpenTrials

Clinical trial condition

Stomach Neoplasms

Explore clinical trials studying Stomach Neoplasms. Study availability and eligibility vary by location and protocol.

1,999 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Stomach Neoplasms trial results

Completed

Chromogranin A as Blood Marker in Cancer Patients

NCT03817866

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +25 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Charité - Universitätsmedizin Berlin Berlin, Germany
View Trial Details
Completed

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma

NCT05327231

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Anyang Tumor Hospital Anyang, Henan, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • The Affiliated Hospital of Nanjing University Medical School Nanjing, Jiangsu, China
View Trial Details
Completed

Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

NCT00911820

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +11 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Texas Oncology Research Dallas, Texas, United States
View Trial Details

Related conditions